Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

But Who’s Counting? Icahn Wins A Biogen Seat, Another Is “Too Close To Call”

Executive Summary

After a drama-packed shareholder meeting on June 3, Carl Icahn claims he won two of four contested seats on the 13-person, Biogen Idec board

You may also be interested in...



Agreement Averts Another Proxy Fight Between Biogen Idec, Icahn

Despite agreeing to support Biogen's nominee slate, Icahn says he still will push for biotech sale.

Agreement Averts Another Proxy Fight Between Biogen Idec, Icahn

Despite agreeing to support Biogen's nominee slate, Icahn says he still will push for biotech sale.

Court Date for Biogen and Elan Set for Sept. 3

The partners, who are litigating over Tysabri, face off earlier than expected.

Related Content

Topics

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel